ArticleCell2022
Potent cross-reactive antibodies following Omicron breakthrough in vaccinees.
Rungtiwa Nutalai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
122 papers cite itlatest 60 shown
this papercites it
ArticleCell2022
Rungtiwa Nutalai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.